|
Use of Patient Registries: Results of the ISPOR Patient Registry Special Interest Group Survey
Elizabeth Molsen RN, Progressive Care Unit, Doylestown Hospital, Doylestown, PA, USA, Jeffrey Trotter MM, Ovation Research Group,
Highland Park, IL, USA, Marilyn Dix Smith PhD, ISPOR, Lawrenceville, NJ, USA
To better understand the needs of the outcomes research
community relating to patient registries, the ISPOR Patient
Registry Special Interest Group (PR SIG) conducted a survey of
ISPOR members. The survey was developed to: a) assess the
involvement of ISPOR members in patient registries, b) assess
types of patient registries used, c) assess use of patient
registries, d) assess use of standard operating procedures,
and e) assess use of electronic data capture for patient
registries.
Of the 295 survey respondents (12% response rate), 37% were
from the pharmaceutical industry, 25% from academia, 22% from
contract research organizations (CROs), 3% from
hospitals/health care providers, 2% each from managed drug or
health care organizations, government, medical device industry
and the remaining 7% from associations, software, information
technology, data supplier organizations.
Personal Involvement in Patient Registries
Survey participants were given multiple options to characterize
their own involvement in patient registries. Of the 377
responses, 60% of responses indicated involvement in a patient
registry, either personally, professionally or both: 28% of
responses indicating the use registries in work and finding
them useful for work, 16% of responses indicating job
responsibilities involving patient registries, and 15% of
responses indicating personal participation in a patient
registry. Less than 1% of responses indicated that registries
were not useful personally or professionally.
Organizational Involvement in Patient Registries
Survey participants were asked to characterize their
organization’s involvement in patient registries. For all
respondents, 35% indicated no involvement by their
organization with patient registries, 21% indicated their
organization is exploring involvement with patient registries,
and 44% indicated that their organization is involved in one
or more patient registries now (with 37% involved in more than
one registry and 7% involved in only one registry).
Organizational involvement in patient registries from
industry, CRO, and academia were:

Organizational Involvement in Patient
Registries in the Future
When asked if their organization will be involved in patient
registries in the future, of the 295 respondents, 50% replied
that their organization will be involved in the future; 34%
replied that their organization may be involved in the future;
15% did not know, while 1% responded that their organization
will not be involved in patient registries in the future.
Responses from industry, CRO, and academia
concerning future involvement with patient registries were:

Types of Patient Registries
If the respondent’s organization was currently involved in
registries, they were asked to categorize the patient
registry. Respondents were allowed multiple options. Of the
431 responses, the registries were characterized as: disease
specific (36%), country specific (22%), productspecific /
branded (15%), global (14%) and/or community-based / regional
registries (13%).
Types of patient registries responses from
industry, CRO, and academia are:

Use of Patient Registry Information
If the respondent’s organization was currently involved in
registries, they were asked why their organization was
involved and were given multiple options from which to choose.
Of the 533 responses, “compile additional outcomes data” (33%)
and “explore ‘real world’ product use” 32%) scored highest,
followed by “compile safety data” (15%), “meet specific
regulatory agency mandate(s)” (12%), and (8%) other reasons,
such as: “to assess long-term costs/resource utilization”,
“establish practice patterns”, “explore opportunities for
patient-care quality improvement”, “use at point of care”,
“generate and validate treatment guidelines”, “study
epidemiology data”, “provide feasibility for randomized
clinical trials”, “to understand treatment patterns”, “unmet
medical needs”, “cost data”, & “budget impact analysis.”
Use
of patient registry information responses from industry, CRO,
and academia were:
Patient Registry Standard Operating Procedures
If the respondent’s organization was involved in registries,
when asked if their organization has specific standard
operating procedures (SOPs) regarding patient registries, of
the 193 responses, 34% have SOPs, 21% were developing them and
45% had no SOPs.
Patient registry SOP responses from industry, CRO, and academia were:

Patient Registry Electronic Data Collection
If the respondent’s organization was involved in registries,
when asked about their utilization of electronic data
collection (EDC) for patient registries, of the 192 responses,
34% indicated that their organization utilizes EDC; 36% will
utilize more EDC in the future and 30% do not utilize EDC for
patient registries.
Patient registry EDC use responses from
industry, CRO, and academia were:
ISPOR Patient Registry SIG Next Steps
When asked, ‘What can the ISPOR Patient Registry SIG do for
you?’ (allowing multiple options), the following were the
recommended actions out of 603 responses:
• Develop guidelines for data analysis (32%)
• Establish standards for data management (27%)
• Develop ISPOR position papers (19%)
• Develop educational sessions on patient registries (12%)
• Develop guidelines for regulatory issues (privacy, IRB,
consent) (9%)
• Other (1 %)
Patient Registry Survey Results Summary
The results of this ISPOR Patient Registry SIG survey
indicate that patient registries are used extensively by
the outcomes research community with a growing need for
them in the future. Disease-specific and country-specific
patient registries were the most common type. Outcomes
research and exploring ‘real world’ product use were the
most common use of patient registries. The use of EDC is
growing and SOPs are not common.
These survey results also indicate that the ISPOR Patient
Registry SIG can assist in the development of: a)
guidelines for data analysis; b) standards for data
management; and c) guidelines for regulatory issues through
ISPOR position papers and education sessions. For more
information about the ISPOR Patient Registry SIG, or to
join this SIG, see:
http://www.ispor.org/sigs/patient_registr.asp.
|